Programs, populations, and payments verified via SAMHSA.
- Level of care
- Outpatient · MAT · Telehealth
- Service settings
- Outpatient, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
- Therapy approaches
- Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Telemedicine/telehealth therapy
- Age groups
- Children/Adolescents
- Special populations
- Adolescents, Adult women, Criminal justice (other than DUI/DWI)/Forensic clients, Clients with co-occurring mental and substance use disorders
- Medications used
- Acamprosate (Campral®), Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable), Medication for mental disorders, Nicotine replacement, Non-nicotine smoking/tobacco cessation
- Recovery supports
- Self-help groups, Assistance with obtaining social services, Mentoring/peer support
- Facility operation
- Private non-profit organization